[CAS NO. 702662-50-8]  STING agonist-1 (G10)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [702662-50-8]

Store
Catalog
SLK-S8954
Brand
Selleck
CAS
702662-50-8

DESCRIPTION [702662-50-8]

Overview

MDLMFCD04062826
Molecular Weight430.88
Molecular FormulaC21H16ClFN2O3S
SMILESO=C(C1=CC=C(SCC(N2CC3=C(F)C=CC=C3Cl)=O)C2=C1)NCC4=CC=CO4

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.3208 mL11.6042 mL23.2083 mL
5 mM0.4642 mL2.3208 mL4.6417 mL
10 mM0.2321 mL1.1604 mL2.3208 mL
50 mM0.0464 mL0.2321 mL0.4642 mL

Description

STING agonist-1 (G10) is a novel human-specific agonist that triggers -associated transcription in human fibroblasts. STING agonist-1 (G10) potently reduces growth of Chikungunya virus (CHIKV) with IC90 of 8.01 μM and blocks replication of Alphavirus species Venezuelan Equine Encephalitis Virus (VEEV) with IC90 of 24.57 μM.

Targets

STING [1]IRF3/IFN [1]CHIKV [1]
(Cell-based assay)
VEEV [1]
(Cell-based assay)
8.01 μM24.57 μM

In vitro

G10 induces IFN/IRF3- but not NF-κB-dependent transcription in human fibroblasts. G10 elicits antiviral activity against New and Old World Alphaviruses. G10 induces STING-dependent synthesis and secretion of bioactive interferon. G10 triggers IRF3-dependent activity and induces innate antiviral mRNA expression in primary human cells.